$HROW
Harrow, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Nashville, TN
HROW chart
What traders are saying about $HROW
Latest postsHarrow, Inc. news
- Harrow Q3 2026 slides: record revenue, product portfolio expansion
Investing.com ·
- Report finds ‘insufficient consideration’ to impact of sight of slaughtered cows
Harrow Times ·
- Harrow Q3 2026 Earnings Call Transcript
Benzinga ·
- Harrow Releases Q3 2026 Financial Results
AlphaStreet ·
- Harrow (HROW) Posts Record Q3 Revenue As New Acquisition Sets Up Q4 Catalyst
Simply Wall St ·
- Hegseth set for Pentagon news conference as he faces possible impeachment
Harrow Times ·
- Multiple women accuse David Walliams of sexual misconduct and grooming
Harrow Times ·
- Top 5 Healthcare and Biotech Pre-Market Gainers on Tuesday: Co-Diagnostics (NASDAQ:CODX) +29.47%, Skye Bioscience, Inc. (NASDAQ:SKYE) +15.93%, Harrow, Inc. (NASDAQ:HROW) +15.13%, Senseonics (NASDAQ:SENS) +13.27%, IceCure Medical (
Kalkine ·
- Why Is Harrow, Inc. (NASDAQ:HROW) Jumping 15.13% in Pre-Market Trade on Tuesday?
Kalkine ·
- David Walliams tried to block publication of sexual misconduct allegations
Harrow Times ·
- Customer's anger as Black Sheep Coffee serve her 'raw' bacon sandwich
Harrow Times ·
- Hugo Palmer excited by dual Bahrain challenge
Harrow Times ·
Harrow, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $272.3M | $199.6M | $130.2M | $88.6M |
| Net income | -$5.1M | -$17.5M | -$24.4M | -$14.1M |
| Diluted EPS | $-0.14 | $-0.49 | $-0.75 | $-0.51 |
| Total assets (year end) | $399.5M | $389.0M | $312.2M | $157.4M |
| Cash and equivalents (year end) | $72.9M | $47.2M | $74.1M | $96.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Harrow, Inc.
- Ticker
- HROW (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Nashville, TN
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1360214
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC
Frequently asked questions
What exchange is Harrow, Inc. listed on?
Harrow, Inc. trades on the Nasdaq under the ticker symbol HROW.
What industry is Harrow, Inc. in?
Harrow, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Harrow, Inc. headquartered?
Harrow, Inc.'s business address on file with the SEC is in Nashville, TN.
When does Harrow, Inc.'s fiscal year end?
Harrow, Inc.'s fiscal year ends on December 31.
How much revenue did Harrow, Inc. report?
Harrow, Inc. reported $272.3M in revenue for calendar year 2025, according to its SEC filings.